Key result
Doxorubicin impairs active myocardial relaxation from the first dose, driven by subsarcolemmal mitochondrial injury.
Why the study?
Anthracycline-induced cardiotoxicity is usually detected after systolic dysfunction, but the onset and cellular basis of earlier diastolic dysfunction are unknown.
Impaired active myocardial relaxation is the earliest functional sign of anthracycline cardiotoxicity, driven by selective injury to subsarcolemmal mitochondria, suggesting early diastolic assessment may improve detection and prevention of heart failure.
Answers are grounded in this paper and cite their sources.
Early diastolic impairment may precede systolic failure in anthracycline exposure; hypothesis-generating for subsarcolemmal mitochondria and NCX1 as preventive targets.
Aims Anthracycline-induced cardiotoxicity is a leading cause of heart failure (HF) in cancer survivors and is usually detected only once systolic dysfunction is established, when myocardial injury may already be advanced. Diastolic dysfunction may occur earlier, but its onset and cellular basis are unknown. We investigated the temporal emergence of diastolic dysfunction during doxorubicin (DOX) exposure and its link to the selective vulnerability of crest/subsarcolemmal mitochondria (SSM) at the cardiomyocyte (CM) surface. Methods and results Using a clinically relevant chronic DOX protocol in adult mice, we performed longitudinal cardiac assessment from the first exposure, combining conventional echocardiography, tissue Doppler, and global longitudinal strain (GLS). Structural and molecular correlates were characterized by atomic force microscopy, transmission electron microscopy, and 3D-quantitative imaging of native cardiac tissue, spatially resolving the CM surface (SSM) from the interior (interfibrillar mitochondria, IFM) compartment. DOX impaired active myocardial relaxation from the first dose with prolonged isovolumic relaxation time and reduced mitral annular e′, whereas passive filling (transmitral filling, left atrial size) was preserved. Ejection fraction remained normal, with an early reduction in GLS. This early relaxation defect coincided with selective remodeling of the surface crest/SSM architecture, evident as crest flattening and progressive SSM loss and with depletion of the crest/SSM determinants Ephrin-B1 and Claudin-5, whereas IFM were affected only later, upon cumulative exposure. Surface SSM injury was accompanied by early, spatially ordered PINK1/Parkin activation, engaging SSM before IFM, and by loss of the sarcolemmal Na⁺/Ca²⁺ exchanger NCX1, likely impairing diastolic Ca 2+ removal. In CM-specific Ephrin-B1-deficient mice, which lack mature crest/SSM, DOX precipitated an accelerated transition to HF with reduced ejection fraction. Conclusions Impaired active relaxation is the earliest functional hallmark of anthracycline cardiotoxicity, underpinned by selective injury of the surface crest/SSM compartment and its Na⁺/Ca²⁺ exchanger NCX1, while IFM and passive filling are initially spared. Diastolic assessment from the first anthracycline cycles may improve early detection and prevention of HF progression.
No takes yet. Share an insight, caveat, or question.
Guilbeau‐Frugier et al. (2025) studied Anthracycline-induced cardiotoxicity. Doxorubicin (DOX) was evaluated on Impaired active myocardial relaxation and selective remodeling of the surface crest/subsarcolemmal mitochondria architecture. Doxorubicin impaired active myocardial relaxation from the first dose, driven by selective injury to surface subsarcolemmal mitochondria and loss of the Na+/Ca2+ exchanger NCX1.
Synapse has enriched 10 related papers. Consider them for comparative context: